109 related articles for article (PubMed ID: 2685188)
21. The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin.
Allegra CJ; Egan GF; Drake JC; Steinberg SM; Swain SM
Adv Exp Med Biol; 1988; 244():107-12. PubMed ID: 3266821
[No Abstract] [Full Text] [Related]
22. [The biochemical modulation of 5-fluorouracil by leucovorin].
Borner M; Brunner K
Schweiz Med Wochenschr; 1991 Aug; 121(33):1149-56. PubMed ID: 1925442
[TBL] [Abstract][Full Text] [Related]
23. Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients.
Bascioni R; Giorgi F; Silva RR; Acito L; Giustini L; De Signoribus G; Giuliodori L; Testa E
Breast Cancer Res Treat; 1997 Sep; 45(3):205-10. PubMed ID: 9386863
[TBL] [Abstract][Full Text] [Related]
24. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.
Van Hazel G; Blackwell A; Anderson J; Price D; Moroz P; Bower G; Cardaci G; Gray B
J Surg Oncol; 2004 Nov; 88(2):78-85. PubMed ID: 15499601
[TBL] [Abstract][Full Text] [Related]
25. The use of mitoxantrone, 5-fluorouracil and high-dose leucovorin in the treatment of advanced breast cancer.
Hainsworth JD
Ann Oncol; 1993; 4 Suppl 2():37-40. PubMed ID: 7688982
[TBL] [Abstract][Full Text] [Related]
26. The effect of leucovorin on the therapeutic index of fluorouracil in cancer patients.
DeLap RJ
Yale J Biol Med; 1988; 61(1):23-34. PubMed ID: 3284210
[TBL] [Abstract][Full Text] [Related]
27. 5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
Vokes EE; Moormeier JA; Ratain MJ; Egorin MJ; Haraf DJ; Mick R; Weichselbaum RR
Cancer Chemother Pharmacol; 1992; 29(3):178-84. PubMed ID: 1733549
[TBL] [Abstract][Full Text] [Related]
28. Phase II study with cisplatin and paclitaxel in combination with weekly high-dose 24 h infusional 5-fluorouracil/leucovorin for first-line treatment of metastatic breast cancer.
Klaassen U; Wilke H; Weyhofen R; Harstrick A; Eberhardt W; Müller C; Korn M; Hanske M; Diergarten K; Seeber S
Anticancer Drugs; 1998 Mar; 9(3):203-7. PubMed ID: 9625430
[TBL] [Abstract][Full Text] [Related]
29. A phase II trial of mitoxantrone plus cyclophosphamide and 5-fluorouracil in modulation with levo-folinate for advanced breast cancer patients.
Leonardi V; Meli M; Palmeri S; Russo A; Rini GB; Peralta S; Rausa L
J Chemother; 1995 Apr; 7(2):160-6. PubMed ID: 7545224
[TBL] [Abstract][Full Text] [Related]
30. Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens.
Francini G; Petrioli R; Messinese S; Pozzessere D; Marsili S; Correale P; Sabatino M; Fiaschi AI
Cancer Chemother Pharmacol; 2002 Oct; 50(4):271-6. PubMed ID: 12357300
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer.
Jones SE; Mennel RG; Brooks B; Westrick MA; Allison MA; Paulson RS; Tilmann K; Rea B
J Clin Oncol; 1991 Oct; 9(10):1736-9. PubMed ID: 1919625
[TBL] [Abstract][Full Text] [Related]
32. Carboplatin plus 5-fluorouracil and leucovorin in previously treated patients with metastatic breast cancer.
Fiorentino MV; Brandes A
Ann Oncol; 1992 Aug; 3 Suppl 3():28-32. PubMed ID: 1390314
[TBL] [Abstract][Full Text] [Related]
33. Mitoxantrone, 5-FU, and leucovorin in breast cancer.
Swain SM; Honig SF
Med Pediatr Oncol; 1994; 22(6):370-4. PubMed ID: 8152397
[TBL] [Abstract][Full Text] [Related]
34. Cyclophosphamide, epirubicin, high-dose folinic acid and 5-fluorouracil (super-FEC) as first-line chemotherapy for advanced breast cancer: preliminary results.
Zaniboni A; Simoncini E; Marpicati P; Montini E; Ferrari V; Ferragni A; Boari L; Marini G
Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1151-5. PubMed ID: 2788577
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer.
Wang F; Wang Z; Zhou N; An X; Xu R; He Y; Li Y
Am J Clin Oncol; 2011 Aug; 34(4):401-5. PubMed ID: 21791984
[TBL] [Abstract][Full Text] [Related]
36. Continuous intravenous infusion of leucovorin and 5-fluorouracil for the treatment of advanced colorectal and breast cancers.
Chiou TJ; Hsieh RK; Liu JM; Tzeng CH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Aug; 52(2):87-91. PubMed ID: 8402373
[TBL] [Abstract][Full Text] [Related]
37. Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer.
Nobile MT; Barzacch MC; Sanguineti O; Chiara S; Gozza A; Vincenti M; Lavarello A; Cognein P; Lionetto R; Percivale PL; Bertoglio S; Murolo C; Esposito M; Vannozzi MO; Rosso R
Anticancer Res; 1998; 18(1B):517-21. PubMed ID: 9568171
[TBL] [Abstract][Full Text] [Related]
38. Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.
Kornek GV; Haider K; Kwasny W; Lang F; Krauss G; Hejna M; Raderer M; Weinländer G; Depisch D; Scheithauer W
Br J Cancer; 1998 Sep; 78(5):673-8. PubMed ID: 9744509
[TBL] [Abstract][Full Text] [Related]
39. Continuous-infusion high-dose leucovorin with 5-fluorouracil and cisplatin for relapsed metastatic breast cancer: a phase II study.
Booser DJ; Walters RS; Holmes FA; Hortobagyi GN
Am J Clin Oncol; 2000 Feb; 23(1):40-1. PubMed ID: 10683074
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer.
Repetto L; Miglietta L; Gardin G; Lanfranco C; Naso C; Merlini L; Giudici S; Venturino A; Campora E; Testore F
Breast Cancer Res Treat; 1994; 30(2):133-7. PubMed ID: 7949211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
